戻る Agenda
Session 7: Variations: The Role of Regulatory Affairs After Marketing Authorization
Session Chair(s)
Diptee A. Gajjar, PhD
Intercontinental Regulatory Strategy Lead
Bristol-Myers Squibb Company, United States
- Change control/product variations